MedTrace Logo

Mesenchymal Stem Cells in Critical Limb Ischemia

NCT00883870 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-03-05

No results posted yet for this study

Summary

This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.

Conditions

  • Critical Limb Ischemia

Interventions

DRUG

mesenchymal stem cells

Intramuscular injection

DRUG

Plasmalyte A

Intramuscular injection

Sponsors & Collaborators

  • Stempeutics Research Pvt Ltd

    lead INDUSTRY

Principal Investigators

  • Suresh K R · Bhagawan Mahaveer Jain Heart Centre, Bangalore

  • Sanjay Desai · M.S.Ramaiah Memorial Hospital, Bangalore

  • Rajiv Parakh · Sri Ganga Ram Hospital, New Delhi

  • Sudhindran S · Amrita Institute of Medical Sciences, Kochi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-02-28
Completion
2012-08-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883870 on ClinicalTrials.gov